Following Bayer’s acquisition of Monsanto, a US agriculture giant, the company is facing a new era in which its pharmaceutical arm is still a highly…

The UK country managers of some of the biggest global pharma companies explain what it takes to manage in the UK market. Erik Nordkamp,…

After spending five years heading market access globally, Lars Bruening returned to a country manager role in the UK; he shares with us his thoughts…

The top 20 pharma companies in Portugal ranked by sales and market share for the year leading up to March 2018. MSD leads the way with EUR 148 million…

The top 20 pharma companies in Ecuador in 2017, ranked by value, for both the retail and public markets. Argentinian firm Roemmers leads the way in…

Florian Ibe, managing director at Bayer Portugal, discusses market access hurdles, as well as Portugal’s expertise in scientific and clinical…

The Top 20 pharma companies in the Polish retail market for 2017 ranked by sales in USD millions. Domestic champion Polpharma leads the way, followed…

A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other developed European markets, with a…

Ekaterina Karpuzova, country commercial lead pharmaceuticals at Bayer Bulgaria, explains how the national healthcare system has evolved over the last…

Alok Kanti, president and CEO of Bayer Canada, draws upon his 27 years of international experience with Bayer to discuss the strategic significance of…

Claus Zieler discusses the Asia Pacific region’s importance to Bayer’s global operations, the company’s commitment to increasing its portfolio…

“Ireland is on a fantastic trajectory in terms of our innovative output and the quality of Irish science." Professor Mark Ferguson, Science…